Graft-versus-host disease (GVHD) after liver transplantation is rare but associated with a very high mortality (over 85%). Most treatments focus on increasing immunosuppression, addition of antibody preparations such as OKT3 and antithymocyte globulin to eliminate the donor lymphocytes, and supporti
Critical role of endogenous Mtv in acute lethal graft-versus-host disease
β Scribed by Isabelle Miconnet; Thierry Roger; Michel Seman; Martine Bruley-Rosset
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 548 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We report here a case of severe steroidβrefractory gastrointestinal graftβversusβhost disease treated with intraβarterial administration of corticosteroids. A 53βyearβold female with nonβHodgkin's lymphoma received peripheral blood hematopoietic stem cell transplant from her HLAβmatched
Background. The major salivary glands are target organs affected by acute graft versus host disease (aGVHD), resulting in severe xerostomia. Methods. We evaluated the function of the major salivary glands in an animal model of aGVHD (B10.SβSJL/J). For the induction of aGVHD, SJL/J mice were subleth
Patients undergoing bone marrow transplantation are at high risk of developing acute graft-versus-host disease (GVHD) which is a primary limiting factor for this procedure inasmuch as it is responsible for high morbidity rates and is associated with poor survival outcome. To provide improved treatme
CHOP, COP plui doxorubicin. ,'According to NCI criteria (Cheson el al. 151). (PD) was registered in one patient. Median time to disease progression for patients in PR or SD was 9 months (range, 1-14 months) (Table I). The results of the prehent study, although based on a small number of patients,